+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Fenhexamid Market by Crop Type (Fruits And Vegetables, Ornamentals And Turf), Formulation Type (Emulsifiable Concentrate, Granules, Suspension Concentrate), Application Method, Distribution Channel, End Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6152795
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Innovative Fungicide Strategies and Evolving Pest Pressures Setting the Stage for Fenhexamid’s Pivotal Role in Protecting Crop Yields

Fenhexamid stands out as a highly selective fungicide with a proven affinity for controlling Botrytis cinerea and related pathogens that threaten key fruit and vegetable crops. Its unique mode of action inhibits critical enzymatic pathways within fungal cell walls, offering robust protection against gray mold outbreaks across a variety of climates. With excellent systemic movement and rainfast properties, fenhexamid ensures consistent efficacy under variable field conditions, making it indispensable for growers seeking reliable disease management solutions.

As regulatory bodies worldwide tighten tolerances for residue levels and encourage reduced reliance on broad-spectrum agents, fenhexamid’s favorable environmental profile and target specificity have cemented its role in modern integrated pest management frameworks. Growers are increasingly balancing the need for high crop quality, sustainability mandates, and resistance management strategies, all of which underscore fenhexamid’s strategic importance and continued investment in formulation innovation.

This introduction sets the stage for an in-depth exploration of transformative shifts in agricultural practices, tariff impacts, segmentation nuances, regional adoption patterns, competitive dynamics, and strategic recommendations. By presenting a holistic overview of the fenhexamid landscape, decision-makers can appreciate the underlying drivers shaping product development, regulatory compliance, and go-to-market approaches as they navigate an evolving global economy and prioritize resilient crop protection programs.

Far-Reaching Shifts in Agricultural Practices Regulatory Landscapes and Sustainability Imperatives Driving Fenhexamid Adoption Across Diverse Farming Systems

The fungicide landscape is undergoing profound realignment as growers, suppliers, and regulatory agencies respond to a cascade of new challenges and priorities. Sustainability imperatives have ushered in stricter residue limits and expanded environmental assessments, prompting a shift away from non-selective chemistries toward more targeted solutions. In parallel, integrated pest management frameworks are becoming the gold standard, with an emphasis on rotating modes of action and combining biological controls to mitigate resistance development.

Meanwhile, technological advances in precision agriculture-from sensor networks to data-driven decision support systems-are enabling growers to tailor fenhexamid applications with unprecedented accuracy. This digital transformation dovetails with increasing consumer demand for cleaner production methods and traceability from field to table.

Finally, evolving global supply chains and post-pandemic logistics recalibrations are influencing raw material sourcing, manufacturing footprints, and distribution efficiencies. Together, these forces create both challenges and opportunities for fenhexamid adoption, driving stakeholders to reimagine deployment strategies that balance cost, compliance, efficacy, and environmental stewardship.

Comprehensive Analysis of United States Tariff Adjustments in 2025 Illuminating Their Complex Influence on Fenhexamid Supply Chains and Pricing Dynamics

Recent tariff adjustments announced for 2025 have introduced new cost dynamics in fungicide imports and exports, directly affecting fenhexamid’s supply chain economics. Duties imposed on precursors and formulated products have elevated landed costs, prompting manufacturers to reevaluate sourcing strategies and optimize production sites closer to end-use markets. In response, some suppliers have initiated dual-sourcing agreements and localized manufacturing partnerships to insulate their supply chains from further trade policy volatility.

The ripple effects of these tariffs extend beyond cost considerations. Distributors and end users are recalibrating procurement cycles, inventory buffers, and contractual terms to accommodate lead time shifts and price fluctuations. As a result, sales models are becoming more flexible, with a gradual move toward shorter, agile supply agreements that prioritize responsiveness and minimize working capital exposure.

Looking ahead, stakeholders are monitoring upcoming trade negotiations and seeking engagement with policymakers to advocate for exemptions or harmonized tariff classifications. This proactive approach aims to foster a more predictable regulatory environment that supports sustained investment in fenhexamid innovation and accessible pricing for growers.

Multifaceted Segmentation Insights Illuminating How Crop Types Formulation Choices Application Methods Distribution Channels and End Uses Shape Fenhexamid

When evaluating fenhexamid’s applications by crop type, its efficacy across both fruits and vegetables as well as ornamentals and turf underscores its versatility. In the fruit and vegetable sector, formulators focus on emulsifiable concentrate and wettable powder variants to enhance coverage in high-density plantings, while ornamental and turf managers often prefer suspension concentrate or granular formulations to maximize soil incorporation and minimize runoff.

Formulation choices directly influence on-farm handling preferences and mixing protocols, with growers balancing ease of use against compatibility with other tank-mix partners. Meanwhile, practitioners leverage multiple application methods-ranging from foliar spray for immediate canopy protection, to seed treatment for early-stage defense, and soil treatment to establish systemic persistence-ensuring that fenhexamid integrates seamlessly into diverse agronomic workflows.

Distribution strategies reflect both direct sales agreements with large commercial growers and indirect sales partnerships through distributors and retailers serving smaller or specialty operations. This layered channel approach enhances accessibility while supporting technical service and localized market intelligence.

Finally, fenhexamid’s end uses stretch from large-scale commercial agriculture, where disease pressure can translate to significant yield risk, to home and garden environments, where ease of application and safety considerations are paramount. This broad reach underscores the importance of tailoring product development and marketing strategies to meet the distinct requirements of each end-user segment.

Nuanced Regional Profiles Revealing Unique Opportunity Landscapes and Adoption Patterns for Fenhexamid Across Americas EMEA and Asia-Pacific Zones

In the Americas, vast commercial production systems for berries and vine crops drive significant demand for fenhexamid, with leading agricultural states innovating large-scale application protocols and resistance monitoring initiatives. Growers here emphasize integrated lab-to-field trials and collaborate closely with research institutions to refine application timing and rates under variable climatic conditions.

Within Europe, the Middle East, and Africa, stringent regulatory frameworks and diverse agroclimatic zones shape fenhexamid adoption in both high-value horticulture and protected cultivation. Regulatory bodies in Western Europe regularly update residue thresholds, compelling formulators to invest in low-dose technologies, while producers in emerging markets are adopting soil treatment approaches to manage unpredictable rainfall and temperature extremes.

Across Asia-Pacific, rapid expansion in greenhouse vegetable production and increasing consumer awareness of food safety have fueled demand for selective fungicides. Extension services and agritech platforms play pivotal roles in disseminating best practices for foliar application and combining chemical and biological modes of action. Key regional hubs are exploring advanced suspension concentrate formulations that deliver optimized droplet size and enhanced rainfastness.

These regional profiles illustrate how localized agronomic challenges, regulatory rigor, and distribution infrastructures converge to define unique opportunity landscapes for fenhexamid’s sustained uptake worldwide.

Strategic Corporate Movements and Collaboration Trends Defined by Key Industry Players Shaping the Future Trajectory of Fenhexamid Development and Deployment

Leading agribusinesses are shaping fenhexamid’s trajectory through a mix of organic growth and strategic collaborations. Major chemical producers have established dedicated R&D centers focused on next-generation active ingredients and co-formulant technologies, driving innovations in controlled-release and microencapsulation systems. By forging partnerships with biotechnology firms, they aim to integrate biostimulants and biocontrol agents that complement fenhexamid’s efficacy and extend its application window.

In parallel, several companies are securing exclusive distribution agreements in emerging markets to strengthen their regional footprint while investing in digital platforms that deliver remote advisory services. These platforms enable real-time disease forecasting and product recommendation engines, enhancing customer engagement and ensuring optimal product performance.

Additionally, joint ventures between formulators and agritech startups are accelerating the development of sensor-driven sprayer systems calibrated to deliver precise fenhexamid dosages under fluctuating environmental conditions. This convergence of formulation science and precision delivery underscores a broader industry trend toward integrated solutions that enhance fungicide stewardship and maximize return on investment.

Actionable Strategic Roadmap Offering Practical Recommendations to Maximize Fenhexamid Effectiveness Regulatory Compliance and Sustainable Integration

To navigate regulatory complexities and sustain fenhexamid’s competitive edge, industry leaders should prioritize the development of low-dose and controlled-release formulations that align with tightening residue standards. Investing in advanced adjuvant systems can further enhance rainfastness and canopy penetration, reducing application frequency and improving environmental profiles.

Cultivating partnerships with regional distributors and digital agritech providers will ensure timely market entry and bolster technical support services. By co-creating disease-prediction models tailored to local climatic patterns, companies can offer data-driven application schedules that optimize efficacy and resource use.

Diversifying manufacturing footprints through tolling agreements or local production joint ventures can hedge against trade policy shifts and logistical constraints. This proactive approach not only mitigates tariff exposure but also fosters stronger ties with domestic regulators and supply chain partners.

Finally, embedding sustainability metrics into product stewardship programs-such as carbon footprint assessments and circular packaging initiatives-will resonate with end users seeking greener solutions. By combining formulation innovation, digital integration, network diversification, and sustainability commitments, fenhexamid stakeholders can secure enduring value and leadership in global disease management portfolios.

Robust Integrated Research Methodology Leveraging Primary Interviews Secondary Data Scientific Literature and Expert Consultations Ensuring Rigor and Relevance

This research combines in-depth primary interviews with growers, formulators, agronomic experts, and regulatory authorities to capture firsthand insights into fenhexamid performance and adoption drivers. Complementing these qualitative inputs, secondary data were analyzed from peer-reviewed journals, patent filings, environmental assessments, and trade association publications to triangulate findings and validate trends.

Disease incidence records and crop protection trial data were systematically reviewed to assess fenhexamid’s efficacy across different climatic zones and application methods. Distribution channel analyses leveraged proprietary datasets detailing prescription rates, inventory flows, and channel profitability metrics to map out supply chain dynamics.

Expert consultations with crop pathologists and agronomists informed the evaluation of resistance management strategies, while engagement with policy advisors illuminated tariff developments and regulatory updates. Statistical tools and scenario-planning frameworks were employed to ensure that insights remain robust under varying trade and climate policy scenarios.

By integrating qualitative narratives with quantitative evidence, this methodology ensures that the analysis delivers both granular detail and strategic perspective-providing stakeholders with actionable intelligence on fenhexamid’s present state and future prospects.

Comprehensive Synthesis Highlighting Key Takeaways Strategic Imperatives and Concluding Perspectives to Inform Stakeholder Decisions on Fenhexamid Deployment

Drawing together diverse threads of analysis, this executive summary underscores fenhexamid’s critical role in modern disease management programs. Its targeted mode of action, environmental compatibility, and versatility across crop types have cemented its status as a core component of integrated pest management frameworks. At the same time, evolving regulatory standards, sustainability mandates, and tariff shifts are reshaping supply chains, pricing dynamics, and go-to-market strategies.

Segmentation insights reveal how growers tailor formulation choices and application methods to specific agronomic needs, while regional profiles highlight distinct regulatory and climatic challenges across the Americas, EMEA, and Asia-Pacific. Competitive intelligence shows that leading companies are investing heavily in formulation innovation, digital advisory platforms, and strategic partnerships to sustain growth and user engagement.

Ultimately, stakeholders who embrace low-dose technologies, diversify sourcing strategies, and integrate data-driven decision support stand to unlock the greatest value. By aligning research, development, and distribution with emerging ecosystem requirements, fenhexamid producers and distributors can secure resilient, sustainable, and profitable disease management solutions for a rapidly changing agricultural landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Crop Type
    • Fruits And Vegetables
    • Ornamentals And Turf
  • Formulation Type
    • Emulsifiable Concentrate
    • Granules
    • Suspension Concentrate
    • Wettable Powder
  • Application Method
    • Foliar Spray
    • Seed Treatment
    • Soil Treatment
  • Distribution Channel
    • Direct Sales
    • Indirect Sales
      • Distributors
      • Retailers
  • End Use
    • Commercial Agriculture
    • Home And Garden
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Bayer AG
  • Adama Agricultural Solutions Ltd
  • UPL Limited
  • Nufarm Limited
  • FMC Corporation
  • Rotam Agrochem International Company Limited
  • Sumitomo Chemical Co. Ltd
  • Certis Europe B.V.
  • Helm AG
  • Sipcam Oxon S.p.A

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory tightening of maximum residue levels for fenhexamid in European soft fruit markets prompting formulation adjustments
5.2. Integration of fenhexamid with biological control agents in integrated pest management programs to combat resistant Botrytis cinerea strains
5.3. Expansion of low-residue fenhexamid formulations in precision agriculture systems using UAV sprayers to optimize dosage and minimize drift
5.4. Development of novel nano-emulsion fenhexamid delivery technologies to enhance rainfastness and prolong disease control on grapevines
5.5. Strategic collaboration between agrochemical manufacturers and large-scale berry producers to co-develop customized fenhexamid-based treatments
5.6. Rising demand for traceable fungicide residues driving investment in rapid on-site residue testing platforms for fenhexamid applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fenhexamid Market, by Crop Type
8.1. Introduction
8.2. Fruits And Vegetables
8.3. Ornamentals And Turf
9. Fenhexamid Market, by Formulation Type
9.1. Introduction
9.2. Emulsifiable Concentrate
9.3. Granules
9.4. Suspension Concentrate
9.5. Wettable Powder
10. Fenhexamid Market, by Application Method
10.1. Introduction
10.2. Foliar Spray
10.3. Seed Treatment
10.4. Soil Treatment
11. Fenhexamid Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Indirect Sales
11.3.1. Distributors
11.3.2. Retailers
12. Fenhexamid Market, by End Use
12.1. Introduction
12.2. Commercial Agriculture
12.3. Home And Garden
13. Americas Fenhexamid Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Fenhexamid Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Fenhexamid Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bayer AG
16.3.2. Adama Agricultural Solutions Ltd
16.3.3. UPL Limited
16.3.4. Nufarm Limited
16.3.5. FMC Corporation
16.3.6. Rotam Agrochem International Company Limited
16.3.7. Sumitomo Chemical Co. Ltd
16.3.8. Certis Europe B.V.
16.3.9. Helm AG
16.3.10. Sipcam Oxon S.p.A
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. FENHEXAMID MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FENHEXAMID MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FENHEXAMID MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FENHEXAMID MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FENHEXAMID MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FENHEXAMID MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FENHEXAMID MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FENHEXAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FENHEXAMID MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FENHEXAMID MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. FENHEXAMID MARKET: RESEARCHAI
FIGURE 26. FENHEXAMID MARKET: RESEARCHSTATISTICS
FIGURE 27. FENHEXAMID MARKET: RESEARCHCONTACTS
FIGURE 28. FENHEXAMID MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FENHEXAMID MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FENHEXAMID MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FENHEXAMID MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FENHEXAMID MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FENHEXAMID MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FENHEXAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FENHEXAMID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FENHEXAMID MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FENHEXAMID MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FENHEXAMID MARKET SIZE, BY ORNAMENTALS AND TURF, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FENHEXAMID MARKET SIZE, BY ORNAMENTALS AND TURF, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FENHEXAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FENHEXAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FENHEXAMID MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FENHEXAMID MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FENHEXAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FENHEXAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FENHEXAMID MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FENHEXAMID MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FENHEXAMID MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FENHEXAMID MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FENHEXAMID MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FENHEXAMID MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FENHEXAMID MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FENHEXAMID MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FENHEXAMID MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FENHEXAMID MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FENHEXAMID MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FENHEXAMID MARKET SIZE, BY RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FENHEXAMID MARKET SIZE, BY RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FENHEXAMID MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FENHEXAMID MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FENHEXAMID MARKET SIZE, BY HOME AND GARDEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FENHEXAMID MARKET SIZE, BY HOME AND GARDEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS FENHEXAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS FENHEXAMID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES FENHEXAMID MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES FENHEXAMID MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 82. CANADA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 83. CANADA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 84. CANADA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 85. CANADA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. CANADA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. CANADA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 88. CANADA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 89. CANADA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 90. CANADA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 96. MEXICO FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 97. MEXICO FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. MEXICO FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 100. MEXICO FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 101. MEXICO FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA FENHEXAMID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 153. GERMANY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 156. GERMANY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 158. GERMANY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 159. GERMANY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. GERMANY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. GERMANY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 162. GERMANY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 163. GERMANY FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 165. FRANCE FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 168. FRANCE FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 170. FRANCE FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 171. FRANCE FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. FRANCE FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. FRANCE FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 174. FRANCE FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 175. FRANCE FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 189. ITALY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 190. ITALY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 191. ITALY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 192. ITALY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 193. ITALY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 194. ITALY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 195. ITALY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ITALY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ITALY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 198. ITALY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 199. ITALY FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 200. ITALY FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 201. SPAIN FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 204. SPAIN FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 206. SPAIN FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 207. SPAIN FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SPAIN FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. SPAIN FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 210. SPAIN FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 211. SPAIN FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 249. DENMARK FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 252. DENMARK FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 254. DENMARK FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 255. DENMARK FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. DENMARK FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. DENMARK FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 258. DENMARK FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 259. DENMARK FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 273. QATAR FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 274. QATAR FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 275. QATAR FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 276. QATAR FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 277. QATAR FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 278. QATAR FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 279. QATAR FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. QATAR FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. QATAR FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 282. QATAR FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 283. QATAR FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 284. QATAR FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 285. FINLAND FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 288. FINLAND FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 289. FINLAND FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 290. FINLAND FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 291. FINLAND FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FINLAND FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. FINLAND FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 294. FINLAND FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 295. FINLAND FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 321. EGYPT FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 324. EGYPT FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 325. EGYPT FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 326. EGYPT FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 327. EGYPT FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. EGYPT FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. EGYPT FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 330. EGYPT FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 331. EGYPT FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 333. TURKEY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 334. TURKEY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 335. TURKEY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 336. TURKEY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 337. TURKEY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 338. TURKEY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 339. TURKEY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. TURKEY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. TURKEY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 342. TURKEY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 343. TURKEY FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 344. TURKEY FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. ISRAEL FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. ISRAEL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 354. ISRAEL FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 357. NORWAY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 358. NORWAY FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 359. NORWAY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 360. NORWAY FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 361. NORWAY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 362. NORWAY FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 363. NORWAY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 364. NORWAY FENHEXAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 365. NORWAY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 366. NORWAY FENHEXAMID MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 367. NORWAY FENHEXAMID MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 368. NORWAY FENHEXAMID MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 369. POLAND FENHEXAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 370. POLAND FENHEXAMID MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 371. POLAND FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 372. POLAND FENHEXAMID MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 373. POLAND FENHEXAMID MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 374. POLAND FENHEXAMID

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fenhexamid Market report include:
  • Bayer AG
  • Adama Agricultural Solutions Ltd
  • UPL Limited
  • Nufarm Limited
  • FMC Corporation
  • Rotam Agrochem International Company Limited
  • Sumitomo Chemical Co. Ltd
  • Certis Europe B.V.
  • Helm AG
  • Sipcam Oxon S.p.A